Cavernous sinus hemangioma: A fourteen year single institution experience

• Published in: Journal of clinical neuroscience Vol. 21; no. 6; pp. 968 - 974
• Main Authors: Bansal, Sumit, Suri, Ashish, Singh, Manmohan, Kale, Shashank Sharad, Agarwal, Deepak, Sharma, Manish Singh, Mahapatra, Ashok Kumar, Sharma, Bhawani Shankar
• Format: Journal Article
• Language: English
• Published: Scotland Elsevier Ltd 01.06.2014
• Subjects: Adult; Cavernous sinus; Cavernous Sinus - pathology; Cavernous Sinus - surgery; Extradural approach; Female; Follow-Up Studies; Gamma Knife radiosurgery; Hemangioma; Hemangioma, Cavernous - diagnosis; Hemangioma, Cavernous - surgery; Humans; Male; Middle Aged; Neurology; Radiosurgery - methods; Transcavernous; Treatment Outcome; Vascular Neoplasms - diagnosis; Vascular Neoplasms - surgery; Cavernous sinus; Transcavernous; Extradural approach; Gamma Knife radiosurgery; Hemangioma
• ISSN: 0967-5868; 1532-2653
• DOI: 10.1016/j.jocn.2013.09.008

Abstract Cavernous sinus hemangioma (CSH) is a rare extra-axial vascular neoplasm that accounts for 2% to 3% of all cavernous sinus tumors. Their location, propensity for profuse bleeding during surgery, and relationship to complex neurovascular structures are factors which present difficulty in excising these lesions. The authors describe their experience of 22 patients with CSH over 14 years at a tertiary care center. Patients were managed with microsurgical resection using a purely extradural transcavernous approach (13 patients) and with Gamma Knife radiosurgery (GKRS; Elekta AB, Stockholm, Sweden) (nine patients). Retrospective data analysis found headache and visual impairment were the most common presenting complaints, followed by facial hypesthesia and diplopia. All but one patient had complete tumor excision in the surgical series. Transient ophthalmoparesis (complete resolution in 6–8 weeks) was the most common surgical complication. In the GKRS group, marked tumor shrinkage (>50% tumor volume reduction) was achieved in two patients, slight shrinkage in five and no change in two patients, with symptom improvement in the majority of patients. To our knowledge, we describe one of the largest series of CSH managed at a single center. Although microsurgical resection using an extradural transcavernous approach is considered the treatment of choice in CSH and allows complete excision with minimal mortality and long-term morbidity, GKRS is an additional tool for treating residual symptomatic lesions or in patients with associated comorbidities making surgical resection unsuitable.